People · Operator
Named in public records as an officer, director or promoter · active 2014–2018 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ninthdecimal, Inc. | — | Other Technology | Series A | $43.1M | $18.5M | 2014 |
| Avant Diagnostics, Inc | — | Biotechnology | Seed | $1.3M | $51.7M | 2018 |
Jeff Stephens at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff Stephens on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Moragne | 1 | 8 |
| Scott Lenet | 1 | 6 |
| Michael Yang | 1 | 6 |
| David Coit | 1 | 5 |
| Kevin McKenzie | 1 | 4 |
| David Horowitz | 1 | 4 |
| GREGORY CAPITOLO | 1 | 4 |
| SHAHAN SOGHIKIAN | 1 | 3 |
| Randall Letcavage | 1 | 2 |
| Chris Albinson | 1 | 2 |
| Dan Hurwitz | 1 | 2 |
| Marc Ruxin | 1 | 2 |
| David Courtney | 1 | 2 |
| Michael Ruxin, M.D. | 1 | 1 |
| Scott VanderMeer | 1 | 1 |
| Jeff Busch | 1 | 1 |
| Robert Trapp | 1 | 1 |
| John Brugmann | 1 | 1 |
| David Staas | 1 | 1 |
| Greg Capitolo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.